Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Non-alcoholic Fatty Liver Disease (NAFLD)
View Full LandscapeTarget Indication
Non-alcoholic Fatty Liver Disease (NAFLD)
Clinical Trial
NCT01811472Last updated: 2/4/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Heart Transplantation
Influenza
Meningococcal Meningitis
Axial Spondyloarthritis
Hypertension